Literature DB >> 25588938

Intermediate Catheters Reduce the Length of Mechanical Thrombectomy Procedures in Acute Basilar Artery Occlusions.

R Mühl-Benninghaus1, H Körner1, A Simgen1, W Reith1, U Yilmaz2.   

Abstract

BACKGROUND AND
PURPOSE: In the past years, technical developments have raised recanalization rates of endovascular treatments of intracerebral artery occlusions in acute ischemic stroke. By using stent retrievers, several prospective trials have reported recanalization rates up to 79 % as well as good neurological outcome in up to 58 % of the cases. The degree of the recanalization and the length of the procedure are factors known to influence the clinical outcome of patients treated endovascularly. Yet, still little is known about factors influencing the angiographic results of thrombectomy procedures. The purpose of this study was to investigate whether the use of intermediate catheters affects the angiographic results of thrombectomy procedures in basilar artery occlusions.
MATERIALS AND METHODS: A total of 47 consecutive patients with acute basilar artery occlusions who underwent endovascular treatment with stent retrievers in our department were retrospectively identified. We analyzed the angiographic data regarding the use of intermediate catheters, the lengths of the procedures, the number of passes of the stent retrievers, the angiographic results, and the site of access to the basilar artery.
RESULTS: Recanalization with modified thrombolysis in cerebral infarction (mTICI) ≥ 2b was achieved in 74.5 %. Intermediate catheters were used in 13 cases. The mean length of the procedures was significantly shorter when intermediate catheters were used (44.8 ± 27.6 vs. 70.7 ± 41.4 min, P = .043). There were no significant differences in the number of passes or in the final mTICI scores.
CONCLUSIONS: The use of intermediate catheters significantly reduces the length of mechanical thrombectomy procedures in acute basilar artery occlusions.

Entities:  

Keywords:  Basilar artery occlusions; Mechanical thrombectomy; Stent retrievers

Mesh:

Year:  2015        PMID: 25588938     DOI: 10.1007/s00062-014-0368-5

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  17 in total

1.  Diagnosis of recanalization of the intracranial artery has poor inter-rater reliability.

Authors:  M Bar; R Mikulik; T Jonszta; A Krajina; M Roubec; D Skoloudik; V Prochazka
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

Review 2.  Basilar artery occlusion.

Authors:  Heinrich P Mattle; Marcel Arnold; Perttu J Lindsberg; Wouter J Schonewille; Gerhard Schroth
Journal:  Lancet Neurol       Date:  2011-11       Impact factor: 44.182

3.  Mechanical thrombectomy with stent retrievers in acute basilar artery occlusion.

Authors:  M Möhlenbruch; S Stampfl; L Behrens; C Herweh; S Rohde; M Bendszus; C Hametner; S Nagel; P A Ringleb; M Pham
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-28       Impact factor: 3.825

4.  Treatment of acute vertebrobasilar occlusion using thrombectomy with stent retrievers: initial experience with 18 patients.

Authors:  M Espinosa de Rueda; G Parrilla; J Zamarro; B García-Villalba; F Hernández; A Moreno
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

5.  Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome.

Authors:  T Brandt; R von Kummer; M Müller-Küppers; W Hacke
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

6.  Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.

Authors:  Jeffrey L Saver; Reza Jahan; Elad I Levy; Tudor G Jovin; Blaise Baxter; Raul G Nogueira; Wayne Clark; Ronald Budzik; Osama O Zaidat
Journal:  Lancet       Date:  2012-08-26       Impact factor: 79.321

7.  Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke.

Authors:  Vitor M Pereira; Jan Gralla; Antoni Davalos; Alain Bonafé; Carlos Castaño; René Chapot; David S Liebeskind; Raul G Nogueira; Marcel Arnold; Roman Sztajzel; Thomas Liebig; Mayank Goyal; Michael Besselmann; Antonio Moreno; Alfredo Moreno; Gerhard Schroth
Journal:  Stroke       Date:  2013-08-01       Impact factor: 7.914

8.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

9.  Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor.

Authors:  Bernd Eckert; Thomas Kucinski; Gustav Pfeiffer; Christoph Groden; Hermann Zeumer
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

10.  Mechanical thrombectomy with the Solitaire device in acute basilar artery occlusion.

Authors:  Isabelle Mourand; Paolo Machi; Didier Milhaud; Marie-Christine Picot; Kyriakos Lobotesis; Caroline Arquizan; Vincent Costalat; Chérif Héroum; Denis Sablot; Stéphane Bouly; Thibault Lalu; Alain Bonafé
Journal:  J Neurointerv Surg       Date:  2013-05-04       Impact factor: 5.836

View more
  3 in total

Review 1.  [Mechanical thrombectomy - technique].

Authors:  U Yilmaz; R Mühl-Benninghaus; W Reith
Journal:  Radiologe       Date:  2016-01       Impact factor: 0.635

2.  Efficacy and safety of direct aspiration first pass technique versus stent-retriever thrombectomy in acute basilar artery occlusion-a retrospective single center experience.

Authors:  Johannes C Gerber; Dirk Daubner; Daniel Kaiser; Kay Engellandt; Kevin Haedrich; Angela Mueller; Volker Puetz; Jennifer Linn; Andrij Abramyuk
Journal:  Neuroradiology       Date:  2017-03-01       Impact factor: 2.804

Review 3.  [Vascular pathologies and vascular anatomical variants of the posterior cranial fossa].

Authors:  Umut Yilmaz
Journal:  Radiologe       Date:  2016-11       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.